Icon plc Stock
Price
Target price
€290.80
€290.80
-1.590%
-4.7
-1.590%
€319.67
16.05.24 / Tradegate
WKN: 932242 / Symbol: ICLR / Name: ICON / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Icon plc Stock
A loss of -1.590% shows a downward development for Icon plc.
Icon plc is currently one of the favorites of our community with 18 Buy predictions and no Sell predictions.
As a result the target price of 319 € shows a slightly positive potential of 9.7% compared to the current price of 290.8 € for Icon plc.
Pros and Cons of Icon plc in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Icon plc vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Icon plc | -1.590% | -0.683% | 7.505% | 47.652% | 12.495% | - | - |
| Alkermes plc | - | -1.786% | -0.901% | -21.429% | -12.000% | 24.294% | -1.786% |
| Ironwood Pharmaceuticals | -2.520% | -7.200% | -21.088% | -39.896% | -43.137% | -41.117% | - |
| Novocure Ltd | -0.830% | 32.158% | 78.326% | -72.485% | 41.786% | -86.061% | - |
Comments
ICON Public Limited (NASDAQ: ICLR) had its price target raised by analysts at TD Cowen from $343.00 to $349.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target lowered by analysts at Evercore ISI from $350.00 to $330.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
ICON Public Limited (NASDAQ: ICLR) had its price target raised by analysts at Robert W. Baird from $362.00 to $363.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ICLR provided by MarketBeat
News
ICON releases its ICON Cares 2023 Report
ICON plc, (NASDAQ:ICLR) a world-leading healthcare intelligence and clinical research organisation, today releases its ICON Cares 2023 Report. This outlines how the company is delivering on its
ICON Announces Pricing of USD 2 Billion Notes
ICON plc (NASDAQ: ICLR) (“ICON”), a world-leading healthcare intelligence and clinical research organization, today announced the pricing of a USD 2 billion SEC-registered bond offering, consisting
ICON Reports First Quarter 2024 Results
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today reported its financial results for the first quarter ended March 31, 2024.
CEO, Dr